| BOC-(+/-)-CIS-3-AMINOCYCLOHEXANE-1-CARBOXYLIC ACID |
顺-3-(叔丁氧羧氨基)环己基甲酸 |
222530-33-8 |
| BOC-D-ALLYLGLYCINE DCHA SALT |
N-叔丁氧羰基-D-烯丙基甘氨酸二环己胺盐 |
221352-64-3 |
| (-)-(1R,3S)-N-FMOC-3-AMINOCYCLOPENTANECARBOXYLIC ACID |
(1R,3S)-N-FMOC-3-氨基环戊烷甲酸 |
220497-67-6 |
| FMOC-L-2-BROMOPHENYLALANINE |
FMOC-L-2-溴苯丙氨酸 |
220497-47-2 |
| (+)-(1S,3R)-N-FMOC-3-AMINOCYCLOPENTANECARBOXYLIC ACID |
(1S,3R)-N-FMOC-3-氨基环戊烷甲酸 |
220497-66-5 |
| Fmoc-(S)-3-Amino-3-phenylpropionic acid |
Fmoc-(S)-3-氨基-3-苯基丙酸 |
209252-15-3 |
| BOC-D-PHE(4-NHBOC)-OH |
FMOC-D-4-BOC-氨基苯丙氨酸 |
214750-77-3 |
| FMOC-PHE(3-I)-OH |
FMOC-L-2-碘苯丙氨酸 |
210282-32-9 |
| FMOC-PHE(3-I)-OH |
FMOC-L-3-碘苯基丙氨酸 |
210282-31-8 |
| ISRIB (trans-isoMer) |
ISRIB(TRANS-ISOMER) 抑制剂 |
1597403-47-8 |
| JNK-IN-8 |
JNK-IN-8 |
1410880-22-6 |
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
| BS-181 HCl |
BS181 |
1397219-81-6 |
| 1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
EPZ005687 |
1396772-26-1 |
| BIX 01294 |
BIX 01294三盐酸盐水合物 |
1392399-03-9 |
| CO-1686 |
CO1686 |
1374640-70-6 |
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
| LY 2874455 |
LY2874455 |
1254473-64-7 |
| LGK-974 |
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺 |
1243244-14-5 |
| LRRK2-IN-1 |
5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 |
1234480-84-2 |
